Dublin, Feb. 17, 2017 -- Research and Markets has announced the addition of the "Pharmaceutical Contract Manufacturing - Global Strategic Business Report" report to their offering.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for Pharmaceutical Contract Manufacturing in US$ Thousand by the following Dosage Forms:
- Injectables
- Solid Dosage Forms
- Liquid & Semi-solid Dosage Forms
The report profiles 112 companies including many key and niche players such as
- Aenova Group (Germany)
- Ajinomoto Althea, Inc. (US)
- Albany Molecular Research Inc. (US)
- Alcami Corporation (US)
- Baxter International, Inc. (US)
- Boehringer Ingelheim GmbH (Germany)
- Catalent Pharma Solutions, Inc. (US)
- Cobra Biologics Holding AB (Sweden)
- CordenPharma International (Germany)
- Dishman Group (India)
- DPx Holdings B.V. (US)
- Fareva Group (Luxembourg)
- Famar Health Care Services (Greece)
- Hospira, Inc. (US)
- Jubilant Life Sciences Limited (India)
- Kemwell Biopharma Pvt. Ltd. (India)
- Lonza Group Ltd. (Switzerland)
- LTS Lohmann Therapie-Systeme AG (Germany)
- NextPharma Technologies Holding Ltd. (UK)
- Nipro Pharma Corporation (Japan)
- Recipharm AB (Sweden)
- Vetter Pharma International GmbH (Germany)
Key Topics Covered:
1. Industry Overview
2. Market Trends & Drivers
3. Competitive Landscape
4. Service Overview
5. Recent Industry Activity
6. Focus On Select Players
7. Global Market Perspective
Total Companies Profiled: 112 (including Divisions/Subsidiaries 125)
- The United States (54)
- Canada (2)
- Japan (7)
- Europe (40)
- - France (6)
- - Germany (10)
- - The United Kingdom (7)
- - Italy (3)
- - Spain (2)
- - Rest of Europe (12)
- Asia-Pacific (Excluding Japan) (21)
- Middle East (1)
For more information about this report visit http://www.researchandmarkets.com/research/ptddk8/pharmaceutical
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Pharmaceuticals, Pharmaceutical Manufacturing


Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth
Meta Is Building an AI Version of Mark Zuckerberg to Interact With Employees
Bendigo and Adelaide Bank Posts Strong Q3 Earnings, Announces AI-Driven Job Cuts
AI Deradicalization Tools: How Chatbots Could Help Combat Violent Extremism Online
Pony.ai, Uber, and Verne Launch Europe's First Commercial Robotaxi Service in Zagreb
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes
Tokyo Electric Power Attracts Major Investors Amid Billion-Dollar Restructuring Push
Lumentum Holdings Rides AI Wave With Order Book Filled Through 2028
Bill Ackman Eyes New Fund to Bet Against Market Complacency
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts
MATCH Act: How New U.S. Chip Legislation Could Freeze China's Semiconductor Ambitions
BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG
Anthropic's Mythos AI Model Sparks Emergency Cybersecurity Meeting With Top U.S. Bank CEOs
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization
OpenAI Addresses Security Vulnerability in macOS App Certification Process
FedEx Pilots and Union Reach Tentative Agreement on 40% Pay Increase 



